Notice: This company has been marked as potentially delisted and may not be actively trading. Taro Pharmaceutical Industries (TARO) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrends Taro Pharmaceutical Industries Short Interest DataTaro Pharmaceutical Industries (TARO) has a short interest of 68,800 shares, representing 0.85% of the float (the number of shares available for trading by the public). This marks a -6.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 45,199 shares to cover all short positions.Current Short Interest68,800 sharesPrevious Short Interest73,600 sharesChange Vs. Previous Month-6.52%Dollar Volume Sold Short$2.95 millionShort Interest Ratio2.5 Days to CoverLast Record DateMay 31, 2024Outstanding Shares37,590,000 sharesFloat Size8,090,000 sharesShort Percent of Float0.85%Today's Trading Volume0 sharesAverage Trading Volume45,199 sharesToday's Volume Vs. Average0% Short Selling Taro Pharmaceutical Industries? Sign up to receive the latest short interest report for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARO Short Interest Over TimeTARO Days to Cover Over TimeTARO Percentage of Float Shorted Over Time Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Taro Pharmaceutical Industries Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202468,800 shares $2.95 million -6.5%0.9%2.5 $42.82 5/15/202473,600 shares $3.12 million +34.6%0.9%2 $42.35 4/30/202454,700 shares $2.33 million +15.9%0.7%1.3 $42.51 4/15/202447,200 shares $1.99 million +18.6%0.6%1 $42.13 3/31/202439,800 shares $1.69 million -32.0%0.5%0.8 $42.34 3/15/202458,500 shares $2.47 million -0.5%0.7%1.1 $42.14 Get the Latest News and Ratings for TARO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 2/29/202458,800 shares $2.47 million -5.2%0.7%1 $42.06 2/15/202462,000 shares $2.62 million -22.4%0.8%1.2 $42.31 1/31/202479,900 shares $3.44 million -18.9%1.0%2 $43.03 1/15/202498,500 shares $4.08 million -11.6%1.2%2.7 $41.44 12/31/2023111,400 shares $4.65 million -16.4%1.4%3.4 $41.78 12/15/2023133,300 shares $5.54 million -12.1%1.7%4.3 $41.58 11/30/2023151,600 shares $5.46 million +0.3%1.9%6.1 $36.00 11/15/2023151,100 shares $5.43 million -22.1%1.9%4.5 $35.93 10/31/2023194,000 shares $6.59 million -16.7%2.4%5.3 $33.98 10/15/2023232,800 shares $8.10 million +2.9%2.9%6.5 $34.78 9/30/2023226,200 shares $8.53 million -11.9%2.8%5.5 $37.71 9/15/2023256,800 shares $9.79 million -35.6%3.2%5.9 $38.14 8/31/2023398,600 shares $15.79 million +82.5%4.9%6.2 $39.62 8/15/2023218,400 shares $8.13 million -3.5%2.7%3.6 $37.24 7/31/2023226,200 shares $8.28 million -12.4%2.8%3.8 $36.59 7/15/2023258,100 shares $9.61 million -14.1%3.2%4.5 $37.22 6/30/2023300,300 shares $11.39 million +324.8%3.7%5.8 $37.93 6/15/202370,700 shares $2.89 million +16.7%0.9%1.4 $40.87 5/31/202360,600 shares $2.24 million -12.4%0.8%2.1 $36.91 5/15/202369,200 shares $2.00 million +24.2%0.9%3.4 $28.87 4/30/202355,700 shares $1.40 million +13.0%0.7%3.4 $25.20 4/15/202349,300 shares $1.21 million -3.0%0.6%3.3 $24.58 3/31/202350,800 shares $1.24 million -17.4%0.6%3.6 $24.32 3/15/202361,500 shares $1.66 million +5.5%0.8%4.6 $27.03 2/28/202358,300 shares $1.76 million +2.5%0.7%4.8 $30.22 2/15/202356,900 shares $1.74 million -7.0%0.7%4.6 $30.52 1/31/202361,200 shares $1.82 million +6.1%0.8%4.8 $29.82 1/15/202357,700 shares $1.77 million -6.2%0.7%4.1 $30.63 12/30/202261,500 shares $1.79 million -20.7%0.8%3.3 $29.04 12/15/202277,500 shares $2.24 million +35.5%1.0%3.8 $28.94 11/30/202257,200 shares $1.72 million +0.7%0.7%2.8 $30.15 11/15/202256,800 shares $1.64 million -5.3%0.7%2.8 $28.92 10/31/202260,000 shares $1.80 million +4.4%0.7%2.8 $29.93 10/15/202257,500 shares $1.74 million -3.2%0.6%2.7 $30.34Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 9/30/202259,400 shares $1.78 million +8.2%0.6%3 $29.98 9/15/202254,900 shares $1.79 million -12.4%0.6%3.1 $32.56 8/31/202262,700 shares $2.11 million +3.3%0.7%2.9 $33.66 8/15/202260,700 shares $2.02 million +14.7%0.6%1.9 $33.26 7/31/202252,900 shares $1.89 million -40.5%0.6%1.7 $35.69 7/15/202288,900 shares $3.36 million +30.9%0.9%2.8 $37.77 6/30/202267,900 shares $2.46 million +3.7%0.7%2.1 $36.16 6/15/202265,500 shares $2.34 million -30.2%0.7%2.1 $35.68 5/31/202293,800 shares $3.43 million +8.4%1.2%3.4 $36.62 5/15/202286,500 shares $3.21 million +10.3%1.1%4.9 $37.16 4/30/202278,400 shares $3.08 million +0.1%1.0%4.4 $39.25 4/15/202278,300 shares $3.13 million -17.4%1.0%4.5 $40.00 3/31/202294,800 shares $4.10 million +12.7%1.2%5.9 $43.26 3/15/202284,100 shares $3.78 million +3.3%1.0%4.6 $44.96 2/28/202281,400 shares $3.98 million +7.4%1.0%4.4 $48.85 2/15/202275,800 shares $3.55 million -8.1%0.9%4.1 $46.79 1/31/202282,500 shares $3.86 million -4.5%1.0%4.6 $46.82 1/15/202286,400 shares $4.20 million -14.4%1.1%4.9 $48.57 12/31/2021100,900 shares $5.06 million +1.0%1.3%6.1 $50.11 12/15/202199,900 shares $4.92 million +3.4%1.2%6.5 $49.22 11/30/202196,600 shares $5.14 million -1.5%1.2%6.8 $53.24 11/15/202198,100 shares $5.30 million -14.1%1.2%6.4 $54.01 10/29/2021114,200 shares $6.35 million -1.4%1.4%7.4 $55.57 10/15/2021115,800 shares $7.39 million -5.9%1.4%7.3 $63.83 9/30/2021123,100 shares $7.83 million -1.6%1.5%6.8 $63.63 9/15/2021125,100 shares $8.36 million -8.5%1.5%6.8 $66.83 8/31/2021136,700 shares $9.27 million +10.7%1.7%6.5 $67.82 8/13/2021123,500 shares $8.73 million +0.2%1.5%5.9 $70.70 7/30/2021123,300 shares $8.78 million +2.1%1.5%5.5 $71.20 7/15/2021120,800 shares $8.09 million +5.4%1.5%5.3 $67.00 6/30/2021114,600 shares $8.25 million -2.1%1.3%5.1 $71.96 6/15/2021117,100 shares $8.84 million -24.5%1.4%4.7 $75.52 5/28/2021155,000 shares $11.01 million +13.0%1.8%6.1 $71.02 5/14/2021137,200 shares $9.95 million +13.7%1.6%5.1 $72.50 4/30/2021120,700 shares $9.00 million -0.5%1.4%4.2 $74.59 4/15/2021121,300 shares $8.83 million -2.2%1.4%4 $72.80 3/31/2021124,000 shares $9.28 million -6.7%1.4%4.1 $74.81 3/15/2021132,900 shares $10.45 million +3.6%1.5%4.4 $78.66 2/26/2021128,300 shares $9.22 million -28.3%1.5%4.3 $71.87 2/12/2021178,900 shares $13.89 million +46.2%2.0%5.5 $77.66 1/29/2021122,400 shares $8.68 million -17.7%1.4%3.9 $70.91 1/15/2021148,800 shares $11.24 million -2.2%1.7%4.9 $75.56 12/31/2020152,100 shares $11.00 million -11.2%1.7%5.2 $72.29 12/15/2020171,200 shares $12.39 million +25.4%2.0%5.7 $72.39 11/30/2020136,500 shares $9.61 million +21.0%1.6%4.7 $70.40 11/15/2020112,800 shares $7.30 million +1.1%1.3%4.5 $64.76 10/30/2020111,600 shares $6.57 million -4.4%1.3%4.7 $58.85 10/15/2020116,700 shares $7.00 million -7.7%1.3%4.4 $60.00 9/30/2020126,400 shares $6.93 million -2.5%1.4%4.7 $54.85 9/15/2020129,700 shares $7.82 million -1.6%1.5%5 $60.27Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 8/31/2020131,800 shares $8.07 million -2.8%1.5%4.6 $61.21 8/14/2020135,600 shares $8.63 million +0.6%1.6%4.6 $63.61 7/31/2020134,800 shares $8.76 million +4.5%1.5%4.2 $65.01 7/15/2020129,000 shares $8.45 million -6.0%1.5%4.3 $65.47 6/30/2020137,200 shares $9.14 million +2.8%1.6%4.3 $66.64 6/15/2020133,500 shares $8.57 million -7.4%1.5%3.8 $64.21 5/29/2020144,200 shares $9.83 million -15.4%1.7%3.4 $68.14 5/15/2020170,500 shares $11.03 million +23.6%2.0%3.7 $64.72 4/30/2020138,000 shares $9.68 million +4.6%1.6%2.9 $70.16 4/15/2020131,900 shares $8.91 million -13.0%1.5%2.6 $67.56 3/31/2020151,600 shares $10.22 million -18.5%1.7%2.9 $67.43 3/13/2020185,900 shares $12.32 million -15.6%2.2%3.5 $66.27 2/28/2020220,200 shares $13.26 million -4.1%2.5%4.2 $60.23 2/14/2020229,500 shares $15.15 million +49.2%2.6%3.5 $66.03 1/31/2020153,800 shares $11.24 million -0.7%1.7%2 $73.08 1/15/2020154,900 shares $11.48 million -5.1%1.7%2 $74.11 12/31/2019163,200 shares $13.64 million -20.7%1.8%2.1 $83.59 TARO Short Interest - Frequently Asked Questions What is Taro Pharmaceutical Industries' current short interest? Short interest is the volume of Taro Pharmaceutical Industries shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 68,800 shares of TARO short. 0.85% of Taro Pharmaceutical Industries' shares are currently sold short. Learn More on Taro Pharmaceutical Industries' current short interest. What is a good short interest ratio for Taro Pharmaceutical Industries? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARO shares currently have a short interest ratio of 2.0. Learn More on Taro Pharmaceutical Industries's short interest ratio. What is a good short interest percentage for Taro Pharmaceutical Industries? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.85% of Taro Pharmaceutical Industries' floating shares are currently sold short. Is Taro Pharmaceutical Industries' short interest increasing or decreasing? Taro Pharmaceutical Industries saw a decline in short interest in May. As of May 31st, there was short interest totaling 68,800 shares, a decline of 6.5% from the previous total of 73,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Taro Pharmaceutical Industries' float size? Taro Pharmaceutical Industries currently has issued a total of 37,590,000 shares. Some of Taro Pharmaceutical Industries' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Taro Pharmaceutical Industries currently has a public float of 8,090,000 shares. How does Taro Pharmaceutical Industries' short interest compare to its competitors? 0.85% of Taro Pharmaceutical Industries' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Taro Pharmaceutical Industries: Blueprint Medicines Co. (6.50%), Nuvalent, Inc. (12.72%), Cytokinetics, Incorporated (13.75%), Corcept Therapeutics Incorporated (20.84%), Viking Therapeutics, Inc. (11.92%), Ionis Pharmaceuticals, Inc. (7.37%), Avidity Biosciences, Inc. (12.29%), Crinetics Pharmaceuticals, Inc. (7.48%), TG Therapeutics, Inc. (23.06%), Biohaven Ltd. (9.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Taro Pharmaceutical Industries stock? Short selling TARO is an investing strategy that aims to generate trading profit from Taro Pharmaceutical Industries as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Taro Pharmaceutical Industries? A short squeeze for Taro Pharmaceutical Industries occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARO, which in turn drives the price of the stock up even further. How often is Taro Pharmaceutical Industries' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARO, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies BPMC Short Interest CYTK Short Interest NUVL Short Interest VKTX Short Interest CORT Short Interest IONS Short Interest CRNX Short Interest RNA Short Interest TGTX Short Interest BHVN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:TARO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taro Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taro Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TARO Stock Alerts